Unfortunately, unlike non-small cell lung cancers including lung SCC, which exhibit a good PD-1 ICI response [4], only 10% of PD-1 ICI-treated HNSCC demonstrated a durable long-term response [5]. The gene discussed is PDCD1; the disease is head and neck squamous cell carcinoma.